← Evidence map

ReviewBiodesign research2024

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics.

Guanglin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39228750